XPO5*rs34334334 was significantly associated with HCC status among different genetic models, including heterozygote (OR = 4.73, 95% CI = 2.38–9.39, p-value < 0.001), homozygote (OR = 39.9, 95% CI = 13.2–121.1, p-value < 0.001), dominant (OR = 10.1, 95% CI = 5.46–18.4, p-value < 0.001), and recessive (OR = 24.1, 95% CI = 8.23–70.8, p-value < 0.001) (Table 3). The gene discussed is XPO5; the disease is hepatocellular carcinoma.